Saroja Pharma Industries India Ltd

AI

Saroja Pharma Industries India Ltd

₹ 40.8 0.00%
19 Oct - close price
About

Incorporated in 2023, Saroja Pharma Ltd is mainly in the business of trading Thionyl Chloride chemical and pharmaceutical intermeddles, etc.[1]

Key Points

Business Overview:[1]
SPIIL is in the business of trading in Pharma API, Pharma Intermediates, Chemicals, Solvents, and other pharmaceutical products, used
for human and veterinary medicine

  • Market Cap ₹ 16.4 Cr.
  • Current Price ₹ 40.8
  • High / Low ₹ 43.6 / 28.0
  • Stock P/E 9.82
  • Book Value ₹ 43.0
  • Dividend Yield 0.00 %
  • ROCE 13.4 %
  • ROE 10.1 %
  • Face Value ₹ 10.0

Pros

  • Stock is trading at 0.95 times its book value
  • Debtor days have improved from 139 to 90.0 days.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 8.62% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025 Sep 2025 Mar 2026
26.54 23.73 21.12 19.36 18.79 35.11 38.76 31.47
25.18 22.28 19.95 18.17 17.58 33.34 37.39 29.04
Operating Profit 1.36 1.45 1.17 1.19 1.21 1.77 1.37 2.43
OPM % 5.12% 6.11% 5.54% 6.15% 6.44% 5.04% 3.53% 7.72%
0.08 0.00 0.39 0.00 0.00 0.00 0.00 0.00
Interest 0.68 0.64 0.83 0.62 0.69 0.72 0.53 0.93
Depreciation 0.00 0.07 0.04 0.06 0.05 0.06 0.06 0.05
Profit before tax 0.76 0.74 0.69 0.51 0.47 0.99 0.78 1.45
Tax % 27.63% 27.03% 27.54% 27.45% 27.66% 29.29% 26.92% 28.28%
0.55 0.54 0.50 0.38 0.34 0.70 0.57 1.04
EPS in Rs 1.90 1.84 1.24 0.95 0.85 1.74 1.42 2.59
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
36.66 55.63 50.19 40.67 53.73 70.13
35.36 53.53 47.47 38.11 50.95 66.32
Operating Profit 1.30 2.10 2.72 2.56 2.78 3.81
OPM % 3.55% 3.77% 5.42% 6.29% 5.17% 5.43%
0.09 0.32 0.16 0.19 0.19 0.02
Interest 0.33 0.80 1.32 1.45 1.41 1.49
Depreciation 0.02 0.05 0.07 0.09 0.11 0.11
Profit before tax 1.04 1.57 1.49 1.21 1.45 2.23
Tax % 28.85% 28.03% 28.86% 27.27% 28.97% 27.80%
0.73 1.14 1.06 0.88 1.03 1.61
EPS in Rs 73.00 3.93 3.61 2.19 2.56 4.00
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 14%
3 Years: 12%
TTM: 31%
Compounded Profit Growth
10 Years: %
5 Years: 18%
3 Years: 16%
TTM: 62%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -12%
1 Year: -8%
Return on Equity
10 Years: %
5 Years: 12%
3 Years: 9%
Last Year: 10%

Balance Sheet

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 0.01 0.23 2.94 4.02 4.02 4.02
Reserves 0.93 3.80 2.15 10.62 11.66 13.27
3.02 6.14 10.18 5.73 9.46 14.41
4.26 5.34 6.07 6.20 14.41 10.04
Total Liabilities 8.22 15.51 21.34 26.57 39.55 41.74
0.09 0.34 2.22 2.51 2.51 2.18
CWIP 0.00 0.00 1.79 6.13 8.61 20.34
Investments 0.00 0.04 0.14 0.20 0.34 0.54
8.13 15.13 17.19 17.73 28.09 18.68
Total Assets 8.22 15.51 21.34 26.57 39.55 41.74

Cash Flows

Figures in Rs. Crores

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-1.05 -3.67 2.19 1.02 1.15 7.44
-0.05 -0.34 -4.82 -4.76 -2.70 -11.68
1.03 4.27 2.73 3.70 1.56 4.25
Net Cash Flow -0.07 0.26 0.10 -0.04 0.01 0.01
Free Cash Flow -1.10 -3.97 -1.54 -3.71 -1.45 -4.06
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit -58% -154% 96% 53% 56% 212%

Ratios

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 71.88 91.73 80.80 145.75 180.56 90.04
Inventory Days 7.23 3.41 31.18 4.10 0.75 4.92
Days Payable 45.43 38.52 47.22 57.45 102.56 48.43
Cash Conversion Cycle 33.68 56.62 64.76 92.39 78.76 46.52
Working Capital Days 22.20 33.07 17.16 71.71 29.89 5.88
ROCE % 33.55% 22.09% 14.93% 12.57% 13.41%

Insights

In beta
Mar 2023 Mar 2024 Mar 2025 Mar 2026
Capital Work-in-Progress
Rs. Lakhs

Log in to view insights

Please log in to see hidden values.

Login
Domestic Revenue Share (India)
%
Export Revenue Share (Asia Pacific + Europe + RoW)
%
IPO Funds Utilized for Manufacturing Unit
Rs. Lakhs
Number of Permanent Employees
count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026Sep 2026
73.02% 73.02% 73.02% 73.02% 73.02% 73.02% 73.02%
26.99% 26.98% 26.98% 26.98% 26.98% 26.98% 26.98%
No. of Shareholders 597506438422435413391

Documents